CYChenchu Yan

Chenchu Yan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chenchu Yan has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Chenghua Weng

    Department of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou, China, suda.edu.cn

    1 shared publication
  • Enzhuo Liu

    Department of Rheumatology, The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, China

    1 shared publication
  • Mengdi Liu

    The Fourth Affiliated Hospital of Soochow University, Institutes of Biology and Medical Sciences, Suzhou Medical College of Soochow University, and

    1 shared publication
  • Xingchen Zhu

    Jiangsu Provincial Key Laboratory of Infection and Immunity, Institute of Biology and Medical Sciences, Soochow University, Building 703, 199 Ren-Ai Road, Suzhou 215123, China

    1 shared publication
  • Xinyue Li

    Department of Rheumatology, The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, China

    1 shared publication
  • Zhenke Wen

    Department of Pulmonary and Critical Care Medicine at the First Affiliated Hospital of Soochow University, Institutes of Biology and Medical Sciences, School of Basic Medical Sciences, Suzhou Medical College of Soochow University, Suzhou, China

    1 shared publication

Latest Publications

  • Open Access

    Lactate programs PBX1 lactylation and mesangial proliferation in lupus nephritis

    by Enzhuo Liu, Chenghua Weng, Chenchu Yan, Xingchen Zhu, Xinyue Li, Mengdi Liu, Zhenke Wen, Zhichun Liu

    Lupus nephritis (LN) constitutes the most common organ-threatening manifestation of systemic lupus erythematosus (SLE), with the pathological proliferation of mesangial cells (MCs) recognized as a critical factor in its pathogenesis and progression. Self-DNA-containing immune complex (DNA-IC) represents a prime pathogenic factor in SLE, yet its pathological effect on MCs remains unclear. In the present study, we elucidated the mechanism underlying the excessive proliferation of MCs following the recognition of DNA-IC in patients with LN. Here, we pinpointed that the excessive proliferation of MCs was attributed to an anomalous transition from the G 1 to the S phase of the cell cycle in patients with LN. Mechanically, the dysfunction of P27 protein resulted in the aberrant G 1 -S phase transition, and the phenomenon was closely related to the ubiquitin-mediated degradation of its key transcription factor, PBX1. This degradation was regulated by lactylation of PBX1 in the site of Lys40 residue. The elevated lactylation level of PBX1 protein was caused by the upregulation of glycolysis levels induced by DNA-IC. Accordingly, targeting lactate production in MCs from patients with LN effectively alleviated their renal inflammation and fibrosis progression. Elevated lactate resulted in PBX1 lactylation, leading to excessive proliferation of MCs and, thus, serving as a promising therapeutic target for LN.